# Sarcopenia and Osteopenia in Individuals With Cerebral Palsy and Influences After Botulinum Neurotoxin Type A Injection

> **NCT05207124** · — · UNKNOWN · sponsor: **National Cheng-Kung University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Cerebral Palsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05207124
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-02
- **Primary completion:** 2023-08
- **Final completion:** 2025-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05207124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05207124, "Sarcopenia and Osteopenia in Individuals With Cerebral Palsy and Influences After Botulinum Neurotoxin Type A Injection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05207124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*